Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G; Italian and Scandinavian Sarcoma Groups. Ferrari S, et al. Among authors: bohling t. J Clin Oncol. 2005 Dec 1;23(34):8845-52. doi: 10.1200/JCO.2004.00.5785. Epub 2005 Oct 24. J Clin Oncol. 2005. PMID: 16246977 Clinical Trial.
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.
Picci P, Böhling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, Ruggieri P, Manfrini M, Ferraro A, Casadei R, Benassi MS, Mancini AF, Rosito P, Cazzola A, Barbieri E, Tienghi A, Brach del Prever A, Comandone A, Bacchini P, Bertoni F. Picci P, et al. Among authors: bohling t. J Clin Oncol. 1997 Apr;15(4):1553-9. doi: 10.1200/JCO.1997.15.4.1553. J Clin Oncol. 1997. PMID: 9193352
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. Among authors: bohling t. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Secondary tumors in bone sarcomas after treatment with chemotherapy.
Ferrari C, Bohling T, Benassi MS, Ferraro A, Gamberi G, Bacci G, Del prever Ab, Sangiorgi L, Ragazzini P, Sollazzo MR, Balladelli A, Picci P. Ferrari C, et al. Among authors: bohling t. Cancer Detect Prev. 1999;23(5):368-74. doi: 10.1046/j.1525-1500.1999.99044.x. Cancer Detect Prev. 1999. PMID: 10468888
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Smeland S, Wiebe T, Böhling T, Brosjö O, Jonsson K, Alvegård TA. Smeland S, et al. Among authors: bohling t. Acta Orthop Scand Suppl. 2004 Apr;75(311):92-8. doi: 10.1080/00016470410001708380. Acta Orthop Scand Suppl. 2004. PMID: 15188671 Review. No abstract available.
Prognostic relevance of C-myc gene expression in giant-cell tumor of bone.
Gamberi G, Benassi MS, Böhling T, Ragazzini P, Molendini L, Sollazzo MR, Merli M, Ferrari C, Magagnoli G, Bertoni F, Picci P. Gamberi G, et al. Among authors: bohling t. J Orthop Res. 1998 Jan;16(1):1-7. doi: 10.1002/jor.1100160102. J Orthop Res. 1998. PMID: 9565066
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.
Ragazzini P, Gamberi G, Benassi MS, Orlando C, Sestini R, Ferrari C, Molendini L, Sollazzo MR, Merli M, Magagnoli G, Bertoni F, Bohling T, Pazzagli M, Picci P. Ragazzini P, et al. Among authors: bohling t. Cancer Detect Prev. 1999;23(2):129-36. doi: 10.1046/j.1525-1500.1999.09907.x. Cancer Detect Prev. 1999. PMID: 10101594
192 results